Adhirons - novel tools for drug discovery

Tue2  Sep03:30pm(30 mins)
Charter 1
 Darren Tomlinson


Novel artificial binding proteins are alternative antibody-like reagents and are useful in many applications from diagnostics to therapeutics. We have developed a novel artificial binding protein, termed Adhiron, that shows remarkable thermal stability and ability to constrain two extended randomised loops of amino acids. Adhirons that bind to target proteins can be isolated from a phage display library quickly and many binders block protein-protein interactions or protein function in vitro and in vivo. This highlights the potential of incorporating the Adhiron platform into a drug discovery pipeline for target validation, identifying druggable domains by structural studies and incorporating them into high throughput drug displacement screens.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021